KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Invested Capital (2016 - 2025)

Historic Invested Capital for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $1.1 billion.

  • AbbVie's Invested Capital fell 8577.62% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 8577.62%. This contributed to the annual value of $70.5 billion for FY2024, which is 104.04% up from last year.
  • According to the latest figures from Q3 2025, AbbVie's Invested Capital is $1.1 billion, which was down 8577.62% from $1.9 billion recorded in Q2 2025.
  • In the past 5 years, AbbVie's Invested Capital registered a high of $92.1 billion during Q4 2021, and its lowest value of $1.1 billion during Q3 2025.
  • Its 5-year average for Invested Capital is $29.3 billion, with a median of $19.4 billion in 2024.
  • In the last 5 years, AbbVie's Invested Capital soared by 78518.72% in 2021 and then plummeted by 9040.55% in 2025.
  • Quarter analysis of 5 years shows AbbVie's Invested Capital stood at $92.1 billion in 2021, then dropped by 12.54% to $80.6 billion in 2022, then fell by 13.38% to $69.8 billion in 2023, then rose by 1.04% to $70.5 billion in 2024, then crashed by 98.37% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $1.9 billion for Q2 2025, and $5.2 billion during Q1 2025.